Genomic Study Presented at ASCO Explores Acquired Resistance to EGFR-targeted Lung Cancer Treatment | GenomeWeb

CHICAGO (GenomeWeb News) – An international team led by investigators from a company called the Cancer Therapeutic Innovation Group is using integrated genomics approaches to assess acquired resistance mechanisms in lung tumors treated with targeted therapy, attendees at the annual American Society of Clinical Oncology meeting heard here yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.